JF
OPRX icon

Jump Financial’s OptimizeRx OPRX Stock Holding History

Jump Financial’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,638
Closed -$226K – 2134
2024
Q1 		$226K Buy
+18,638
New +$270K 0.01% 1609
2023
Q4 		– Sell
-13,032
Closed -$101K – 2106
2023
Q3 		$101K Buy
+13,032
New +$142K ﹤0.01% 1675
2023
Q2 		– Sell
-32,300
Closed -$473K – 2063
2023
Q1 		$473K Buy
32,300
+22,100
+217% +$370K 0.02% 921
2022
Q4 		$171K Sell
10,200
-4,000
-28% -$69.2K 0.01% 1325
2022
Q3 		$210K Buy
+14,200
New +$281K 0.01% 1324
2022
Q2 		– Sell
-6,000
Closed -$227K – 1909
2022
Q1 		$227K Sell
6,000
-8,900
-60% -$394K 0.01% 1229
2021
Q4 		$925K Buy
+14,900
New +$1.13M 0.06% 416

Other funds holding OPRX

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Samjo Management New York $293M AUM 57.03% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return

Jump Financial's OPRX Position: Q2 2024 in Review

Jump Financial sold out of OptimizeRx (OPRX) in Q2 2024, closing a stake of 18,638 shares — an estimated $226K sold.

Jump Financial first reported a position in OPRX in Q4 2021 and held it in 7 quarters. The position peaked at $925K in Q4 2021. 92 funds tracked by Wall St. Rank hold OPRX as of Q2 2024.

  • Jump Financial reported no remaining OptimizeRx position as of Q2 2024 after selling out during the quarter.
  • Jump Financial sold 18,638 OptimizeRx shares in Q2 2024, an estimated $226K.
  • Jump Financial first reported a position in OptimizeRx in Q4 2021 and held it in 7 quarters.
  • Jump Financial's OptimizeRx position peaked at $925K in Q4 2021.
  • 92 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2024.

Based on Jump Financial's 13F filing for Q2 2024, filed 14 Aug 2024.